Outside political groups not always what they appear

Washington Post

18 March 2019 - As ominous music plays in the background, the narrator of a radio ad echoes objections from drugmakers by warning that a Trump administration proposal to apply international pricing to certain Medicare drugs would be a nightmare for seniors.

The one-minute spot is the handiwork of the Alliance for Patient Access, a nonprofit group that gives off a consumer-friendly vibe yet is bankrolled by the powerful pharmaceutical industry. It’s also closely aligned with a Washington lobbying and public relations firm, Woodberry Associates, whose president, Brian Kennedy, is the nonprofit’s executive director.

As Congress and the Trump administration aim to lower prescription drug costs, outside groups like the Alliance for Patient Access are seeking to sway the outcome. But not all of these organisations are clear about who they actually represent. Their names can obscure the source of the message and they’re cagey about where they get their funding.

Read Washington Post article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing